Abstract Submission
for the Special isirv-AVG Virtual Conference on 'Therapeutics for COVID-19'

Late breaker deadline: midnight, US Pacific time, 25th of September 2020


Submission Category: Abstracts may be submitted under one of the following categories:

COVID-19 Clinical Spectrum
COVID-19 Viral Replication Kinetics
COVID-19 Immunopathogenesis
SARS-CoV-2 Antivirals
Pre-clinical studies
Clinical trial outcomes
Monoclonal and polyclonal antibodies, convalescent plasma
Combination Therapy Approaches

Publication: Upon submission of an abstract, the author provides consent to allow isirv-AVG to publish the abstract in the Programme/Abstract Book.

Co-Author Approval: Ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Regular abstracts cannot be changed or withdrawn after 11th September; late-breaker abstracts cannot be changed or withdrawn after 25th of September 2020.

Author Disclosure: All abstract authors are required to disclose any conflict of interest.

Changes to Abstract: You are able to edit your abstract until the submission deadline. After the submission deadline, only minor abstract changes (author or institution changes, disclosure or keyword updates) are allowed. The deadline for minor updates is 11th September for regular abstracts and 25th of September 2020 for late-breaker abstracts. Any corrections and/or changes will not be accepted after these dates.

Abstract Receipt Confirmation: You should receive email confirmation within two hours of submitting your abstract. If, after checking your spam folder, you have not received this confirmation then please contact Quad Logic technical support.

Abstract policy, deadlines, notifications, programming, general conference questions, contact isirv AVG Conference secretariat.
Technical support questions related to problems with online abstract submission, contact Quad Logic.


Abstract Preparation: Abstracts must conform exactly to the instructions provided for electronic submission. Abstracts must be submitted in English and all presentations will be in English.

Layout of Submission: Each abstract will need to include a title, background, methods, and conclusion.

Character Limit: A complete abstract submission will be a maximum of 2,750 characters. This includes the background, methods, tables, figures, results, conclusions and spaces. This does NOT include the authors and institutions.

File Attachment: File attachment is only for additional figures or tables with the content character count taken into consideration. This facility is not used to upload abstracts by pdf.